Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study

<p>Abstract</p> <p>Background</p> <p>The risk-benefit ratio of aspirin therapy in prevention of cardiovascular disease (CVD) remains contentious, especially in type 2 diabetes. This study examined the benefit and harm of low-dose aspirin (daily dose < 300 mg) in pati...

Full description

Bibliographic Details
Main Authors: Chan Francis K, Ma Ronald C, Kong Alice P, Ko Gary T, Tong Peter C, Lui Augustine, Stewart Derek, So Wing-yee, Leung Wilson Y, Yang Xilin, Chiang Sau-chu, Chan Juliana C
Format: Article
Language:English
Published: BMC 2009-10-01
Series:Cardiovascular Diabetology
Online Access:http://www.cardiab.com/content/8/1/57

Internet

http://www.cardiab.com/content/8/1/57

Similar Items